![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ferroptotic therapy in cancer: benefits, side effects, and risks
Jiandong Diao, Yuanyuan Jia, Enyong Dai, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Jiandong Diao, Yuanyuan Jia, Enyong Dai, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Showing 13 citing articles:
Targeting GPX4 in ferroptosis and cancer: chemical strategies and challenges
Jiao Liu, Daolin Tang, Rui Kang
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 8, pp. 666-670
Closed Access | Times Cited: 11
Jiao Liu, Daolin Tang, Rui Kang
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 8, pp. 666-670
Closed Access | Times Cited: 11
Ferroptosis crosstalk in anti-tumor immunotherapy: molecular mechanisms, tumor microenvironment, application prospects
Y. F. Lu, Xiao‐Ting Xie, Lianxiang Luo
APOPTOSIS (2024) Vol. 29, Iss. 11-12, pp. 1914-1943
Closed Access | Times Cited: 6
Y. F. Lu, Xiao‐Ting Xie, Lianxiang Luo
APOPTOSIS (2024) Vol. 29, Iss. 11-12, pp. 1914-1943
Closed Access | Times Cited: 6
Targeting ferroptosis: the role of non-coding RNAs in hepatocellular carcinoma progression and therapy
Weijia Wang, Behishta Hashimi, Ping Wang
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Weijia Wang, Behishta Hashimi, Ping Wang
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Cross-talks of GSH, mitochondria, RNA m6A modification, NRF2, and p53 between ferroptosis and cuproptosis in HCC: A review
Leihan Wang, Zhenni ChenLiu, Daorong Wang, et al.
International Journal of Biological Macromolecules (2025), pp. 140523-140523
Closed Access
Leihan Wang, Zhenni ChenLiu, Daorong Wang, et al.
International Journal of Biological Macromolecules (2025), pp. 140523-140523
Closed Access
Tumor-derived miR-203a-3p potentiates muscle wasting by inducing muscle ferroptosis in pancreatic cancer
Yumeng Hu, Yifu Hu, Shaobo Zhang, et al.
Cancer Letters (2025), pp. 217523-217523
Closed Access
Yumeng Hu, Yifu Hu, Shaobo Zhang, et al.
Cancer Letters (2025), pp. 217523-217523
Closed Access
NFE2L2 and ferroptosis resistance in cancer therapy
Daolin Tang, Rui Kang
Cancer Drug Resistance (2024)
Open Access | Times Cited: 4
Daolin Tang, Rui Kang
Cancer Drug Resistance (2024)
Open Access | Times Cited: 4
Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL+ leukemia stem cells
Chengwu Zeng, Dingrui Nie, Xianfeng Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Chengwu Zeng, Dingrui Nie, Xianfeng Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Ferroptosis in Cancer: A new perspective on T cells
Yuping Lai, Chun-Xia Huang, Jia‐Qiang Wu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113539-113539
Closed Access | Times Cited: 1
Yuping Lai, Chun-Xia Huang, Jia‐Qiang Wu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113539-113539
Closed Access | Times Cited: 1
Ferroptosis meets microRNAs: a new frontier in anti-cancer therapy
J N Ghosal, V K Sinchana, Sanjiban Chakrabarty
Free Radical Biology and Medicine (2024)
Open Access | Times Cited: 1
J N Ghosal, V K Sinchana, Sanjiban Chakrabarty
Free Radical Biology and Medicine (2024)
Open Access | Times Cited: 1
Biomimetic Fe3+ metal-phenolic networks enable DNAzyme and Cas9 RNP delivery for synergistic tumor ferroptosis-immunotherapy
Chao Chen, Xueting Shen, Silin Shi, et al.
Chemical Engineering Journal (2024) Vol. 499, pp. 156050-156050
Closed Access
Chao Chen, Xueting Shen, Silin Shi, et al.
Chemical Engineering Journal (2024) Vol. 499, pp. 156050-156050
Closed Access
Ferroptosis: Potential therapeutic targets and prognostic predictions for acute myeloid leukemia (Review)
Wenlu Zhang, Wen Wen, Ran Tan, et al.
Oncology Letters (2024) Vol. 28, Iss. 6
Open Access
Wenlu Zhang, Wen Wen, Ran Tan, et al.
Oncology Letters (2024) Vol. 28, Iss. 6
Open Access
Tumor Biology Hides Novel Therapeutic Approaches to Diffuse Large B-Cell Lymphoma: A Narrative Review
Romana Masnikosa, Zorica Cvetković, David Pirić
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11384-11384
Open Access
Romana Masnikosa, Zorica Cvetković, David Pirić
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11384-11384
Open Access
ANP32E promotes esophageal cancer progression and paclitaxel resistance via P53/SLC7A11 axis-regulated ferroptosis
Li‐Ying Sun, Shaobo Ke, Boxin Li, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113436-113436
Closed Access
Li‐Ying Sun, Shaobo Ke, Boxin Li, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113436-113436
Closed Access
Targeting GPX4 degradation through disulfiram: A novel mechanism for ferroptosis induction in leukemia cells
Caixia Wang, Shunqing Wang
Cell investigation. (2024) Vol. 1, Iss. 1, pp. 100006-100006
Open Access
Caixia Wang, Shunqing Wang
Cell investigation. (2024) Vol. 1, Iss. 1, pp. 100006-100006
Open Access
Ferroptosis in Tumor Microenvironment: An Alternative Mode of Cell Death and Its Clinical Significance in Cancer
Paramita Paul, Subhasis Barik
(2024) Vol. 1, Iss. 2, pp. 69-75
Closed Access
Paramita Paul, Subhasis Barik
(2024) Vol. 1, Iss. 2, pp. 69-75
Closed Access